Cell and Gene Therapy Catapult GMP Manufacturing Report 2024 Highlights @cellandgenetherapycatapult
Cell and Gene Therapy Catapult GMP Manufacturing Report 2024 Highlights @cellandgenetherapycatapult
Uploaded January 2025 | Updated September 2026, 2 weeks ago
The Cell and Gene Therapy Catapult’s Good Manufacturing Practice (GMP)
Manufacturing Survey identifies the capability and capacity for manufacturing cell and gene therapies in the UK.

The report has been carried out every year since 2014 to provide up-to-date information and track changes in the industry.

Read the report: ct.catapult.org.uk/resources/manufacturing-surveys
Cell and Gene Therapy Catapult GMP Manufacturing Report 2024 HighlightsIntroducing the Cell and Gene Therapy CatapultCell and Gene Therapy Catapults Edinburgh office and laboratoriesATAC Case Study - Andy Chapman, GSKEmployee Spotlight: Shereece Szelwicki, Senior Tech Transfer SpecialistCell and Gene Therapy Catapults Braintree Manufacturing Innovation CentreATTC network event 2024: Interview with Kath Bainbridge, Department of Health and Social CareCell and Gene Therapy Catapults London Office and LaboratoriesWhat is ATAC and how does it support the advanced therapies industry?ATTC network event 2025: Interview with Jacqueline Barry, Cell and Gene Therapy CatapultFireside Chat: Challenges and perspectives on gene therapyATTC network event 2025: Interview with Fiona Thistlethwaite, iMATCH ATTC
Cell and Gene Therapy Catapult |

Cell and Gene Therapy Catapult GMP Manufacturing Report 2024 Highlights

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER